Skip to main content

Table 3 OS of all patients, Child A and Child B/C subgroups and patients with/without portal invasion

From: Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

 

cTACE (n = 174)

DEB-TACE (n = 76)

p

OS (days)

median (CI)

median (CI)

 

All patients

409 (321–488)

369 (310–589)

0.76

Child A

602 (484–792)

627 (364–788)

0.40

Child B/C

223 (165–315)

226 (114–335)

0.53

Portal invasion

   

Yes

221 (143–285)

194 (97–310)

0.82

No

501 (410–607)

386 (325–634)

0.48

  1. OS overall survival, CI confidence interval, DEB-TACE drug-eluting bead transarterial chemoembolization, cTACE conventional TACE
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us